Welcome to our dedicated page for American Oncology Network news (Ticker: $AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect American Oncology Network's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of American Oncology Network's position in the market.
American Oncology Network (AONC) announced that Dave Gould will step down as Chief Financial Officer, with David Afshar appointed as interim CFO. Afshar brings over 25 years of healthcare finance experience to the role, having worked in both private equity-backed and public company environments. AONC expressed gratitude to Gould for his contributions and emphasized their commitment to providing top-notch cancer care.
American Oncology Network (AONC) will release its first quarter 2024 financial results on May 15, 2024, followed by a conference call and webcast at 8:30 a.m. Eastern Time. Investors can access the call through specific phone numbers and a passcode, with a replay available later. The financial results and webcast will be accessible on the Investor Relations section of the Company's website.
